Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria
- J. Franca, M. P. De Luca, +4 authors André A G Faraco
- Biology, Medicine
- BMC Complementary and Alternative Medicine
- 12 December 2014
BackgroundDental caries is the most prevalent oral disease in several Asian and Latin American countries. It is an infectious disease and different types of bacteria are involved in the process.… Expand
Antileishmanial activity and cytotoxicity of Brazilian plants.
- T. G. Ribeiro, M. A. Chávez-Fumagalli, +10 authors R. Castilho
- Biology, Medicine
- Experimental parasitology
- 1 August 2014
Leishmaniasis is a major public health problem, and the alarming spread of parasite resistance has increased the importance of discovering new therapeutic products. The present study aimed to… Expand
In vitro release and characterization of chitosan films as dexamethasone carrier.
- L. B. Rodrigues, H. F. Leite, M. Yoshida, J. B. Saliba, A. S. Cunha, André A G Faraco
- Chemistry, Medicine
- International journal of pharmaceutics
- 23 February 2009
Chitosan, a biodegradable and biocompatible polysaccharide, is a potentially useful material in various fields. We produced mono and bilayer chitosan films containing dexamethasone as a drug carrier… Expand
Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
- D. V. Mendonça, Letícia M R Lage, +10 authors E. A. Coelho
- Biology, Medicine
- Experimental parasitology
- 1 October 2016
In the present study, a Poloxamer 407-based amphotericin B (AmpB)-containing polymeric micelles system (AmpB/M) was employed in the treatment of Leishmania amazonensis-infected BALB/c mice.… Expand
New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment.
- M. A. Chávez-Fumagalli, T. G. Ribeiro, +8 authors E. A. Coelho
- Medicine
- Revista da Sociedade Brasileira de Medicina…
- 27 June 2015
Leishmaniasis is one of the six major tropical diseases targeted by the World Health Organization. It is a life-threatening disease of medical, social and economic importance in endemic areas. No… Expand
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
- T. G. Ribeiro, M. A. Chávez-Fumagalli, +14 authors André A G Faraco
- Materials Science, Medicine
- International journal of nanomedicine
- 14 February 2014
The study reported here aimed to develop an optimized nanoparticle delivery system for amphotericin B (AmpB) using a polyelectrolyte complexation technique. For this, two oppositely charged polymers… Expand
An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis
- T. G. Ribeiro, J. Franca, +13 authors M. A. Chávez-Fumagalli
- Materials Science, Medicine
- International journal of nanomedicine
- 19 November 2014
Amphotericin B (AmpB) is active against leishmaniasis, but its use is hampered due to its high toxicity observed in patients. In this study, a nanoparticles-delivery system for AmpB (NQC-AmpB),… Expand
Antileishmanial activity of standardized fractions of Stryphnodendron obovatum (Barbatimão) extract and constituent compounds.
- T. G. Ribeiro, André Márcio do Nascimento, +12 authors R. Castilho
- Biology, Medicine
- Journal of ethnopharmacology
- 13 May 2015
ETHNOPHARMACOLOGICAL RELEVANCE
Stryphnodendron obovatum Benth. is a Brazilian tree used to treat skin ulceration, promote wound healing, and inhibit the growth of protozoa, including Trypanosoma and… Expand
Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis.
- M. C. Duarte, Grasiele S. V. Tavares, +13 authors E. A. Coelho
- Biology, Medicine
- Experimental parasitology
- 1 July 2016
In recent years, considerable attention has been given to identify new antileishmanial products derived from medicinal plants, although, to date, no new effective compound has been recently applied… Expand
New mesalamine polymeric conjugate for controlled release: Preparation, characterization and biodistribution study
- Aina L A Cesar, F. A. Abrantes, +5 authors André A G Faraco
- Chemistry, Medicine
- European journal of pharmaceutical sciences…
- 1 January 2018
ABSTRACT Mesalamine (5‐ASA) consists of the first‐line therapy for the treatment of ulcerative colitis; however, it has low bioavailability, can cause several systemic adverse events, and has low… Expand
...
1
2
...